Q1 2026 Precigen Inc Earnings Call Transcript

May 13, 2026 / 08:30 PM GMT

Release Date Price: $4.15 (+1.72%)

Transcript 8-K10-Q

Key Points

Positve

Precigen Inc (PGEN) reported strong revenue growth with Q1 2026 net product revenue for Papcimius reaching $21.6 million, up from $3.4 million in Q4 2025.
The launch of Papcimius has been well-received, with significant uptake among both major medical centers and community practices.
The FDA's full approval and broad label for Papcimius, without restrictions on the number of surgeries prior to treatment, has facilitated its rapid adoption.
Comprehensive payer coverage has been achieved, with more than 90% of insured lives in the U.S. covered, supporting patient access to Papcimius.
The company has a strong financial position, with $56.7 million in cash equivalents and investments, and expects to reach cash flow breakeven by the end of 2026 without needing additional funding.

Negative

Despite strong revenue growth, Precigen Inc (PGEN) reported an operating loss of $6 million for Q1 2026.
Research and development expenses are expected to increase as the year progresses, potentially impacting future profitability.
Selling, general, and administrative expenses increased by $8.7 million from the prior year's first quarter, driven by commercial activities related to Papcimius.
Cash used in operations for Q1 was $43.8 million, which included $13 million of non-recurring cash outflows, indicating high operational costs.
The company is not providing specific guidance for future quarters, creating uncertainty about the pace of revenue growth and financial performance.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PGEN.OQ - Precigen Inc
Q1 2026 Precigen Inc Earnings Call
May 13, 2026 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon, ladies and gentlemen, and welcome to the Precedent First Quarter 2026 Financial Results and Business Updates Conference Call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. If at any time during this call you require immediate assistance, please press *0 for the operator. This call is being recorded on Wednesday, May 13, 2026. And I would now like to turn the conference over to Mr. Stephen Harasim. Please go ahead. Sir.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, operator, and thank you for

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.